How to choose the right vial for next-generation therapies with Diana Löber
Primary packaging is a crucial component of drug formulation. Even the most advanced medication can lose its efficacy if stored in a container that fails to maintain its stability over time.
With the growing prevalence of biologics, the range of molecules and applications continues to expand, leading to increasingly diverse requirements for primary packaging. For example, more than 50% of biologics require lyophilization, which can introduce challenges such as ""fogging."" Additionally, some molecules are highly sensitive to glass leachables, particularly with low-fill volumes, while others may adsorb to the container's surface, affecting dosage accuracy or necessitating overfilling.
At SCHOTT Pharma, we offer the most extensive range of vial solutions designed to address these specific challenges. Join our upcoming webinar to explore our advanced vial solutions, tailored to meet the demands of next-generation drugs.
With the growing prevalence of biologics, the range of molecules and applications continues to expand, leading to increasingly diverse requirements for primary packaging. For example, more than 50% of biologics require lyophilization, which can introduce challenges such as ""fogging."" Additionally, some molecules are highly sensitive to glass leachables, particularly with low-fill volumes, while others may adsorb to the container's surface, affecting dosage accuracy or necessitating overfilling.
At SCHOTT Pharma, we offer the most extensive range of vial solutions designed to address these specific challenges. Join our upcoming webinar to explore our advanced vial solutions, tailored to meet the demands of next-generation drugs.
